Reviva Pharmaceuticals Holdings, Inc. Stock Redeemed or Called During Period, Shares
Reviva Pharmaceuticals Holdings, Inc. (RVPH) had Stock Redeemed or Called During Period, Shares of 595.89 thousand shares as of 2020-02-18, per its 10-K filed 2020-05-04.
Discontinued › Shareholders' Equity
us-gaap:StockRedeemedOrCalledDuringPeriodShares · last filed 2020-05-04
- 2020-02-18: Stock Redeemed or Called During Period, Shares 595.89K shares.
| Period end | Stock Redeemed or Called During Period, Shares |
|---|---|
| 2020-02-18 | 595.89K shares 10-K · filed 2020-05-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Dermata Therapeutics, Inc. (DRMA) | United States | $0.005B | -0.62 |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| REVELATION BIOSCIENCES, INC. (REVB) | United States | $0.004B | |
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |